NM_001377405.1:c.1560+95G>A

Variant names:

• chr3-63990469-G-A
• rs2241821
• NM_001377405.1:c.1560+95G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_001377405.1(ATXN7):​c.1560+95G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0827 in 1,459,308 control chromosomes in the GnomAD database, including 5,535 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency:
  • Genomes: 𝑓 0.069 (466 hom., cov: 32)
  • Exomes 𝑓: 0.084 (5069 hom.)
• Consequence: ATXN7 NM_001377405.1 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -1.25
• Publications: 5 publications found

Genes affected

ATXN7 (HGNC:10560): (ataxin 7) The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the 'pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. This locus has been mapped to chromosome 3, and it has been determined that the diseased allele associated with spinocerebellar ataxia-7 contains 37-306 CAG repeats (near the N-terminus), compared to 4-35 in the normal allele. The encoded protein is a component of the SPT3/TAF9/GCN5 acetyltransferase (STAGA) and TBP-free TAF-containing (TFTC) chromatin remodeling complexes, and it thus plays a role in transcriptional regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2016]

ATXN7 Gene-Disease associations (from GenCC):

• spinocerebellar ataxia 7

  Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
• spinocerebellar ataxia type 7

  Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.84).
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.129 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
ATXN7	NM_001377405.1	c.1560+95G>A		intron_variant	Intron 10 of 12	ENST00000674280.1	NP_001364334.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
ATXN7	ENST00000674280.1	c.1560+95G>A		intron_variant	Intron 10 of 12		NM_001377405.1	ENSP00000501377.1

Frequencies

GnomAD3 genomes AF: 0.0693 AC: 10546 AN: 152184 Hom.: 465 Cov.: 32

Gnomad AFR AF: 0.0238

Gnomad AMI AF: 0.00877

Gnomad AMR AF: 0.120

Gnomad ASJ AF: 0.101

Gnomad EAS AF: 0.136

Gnomad SAS AF: 0.0943

Gnomad FIN AF: 0.0485

Gnomad MID AF: 0.108

Gnomad NFE AF: 0.0804

Gnomad OTH AF: 0.0864

GnomAD4 exome AF: 0.0843 AC: 110129 AN: 1307006 Hom.: 5069 Cov.: 20 AF XY: 0.0842 AC XY: 54786 AN XY: 650832

African (AFR) AF: 0.0217 AC: 659 AN: 30390

American (AMR) AF: 0.175 AC: 7148 AN: 40822

Ashkenazi Jewish (ASJ) AF: 0.0996 AC: 2258 AN: 22678

East Asian (EAS) AF: 0.133 AC: 5076 AN: 38250

South Asian (SAS) AF: 0.0943 AC: 7204 AN: 76394

European-Finnish (FIN) AF: 0.0493 AC: 2408 AN: 48812

Middle Eastern (MID) AF: 0.0903 AC: 385 AN: 4262

European-Non Finnish (NFE) AF: 0.0811 AC: 80328 AN: 990364

Other (OTH) AF: 0.0847 AC: 4663 AN: 55034

GnomAD4 genome AF: 0.0693 AC: 10551 AN: 152302 Hom.: 466 Cov.: 32 AF XY: 0.0688 AC XY: 5121 AN XY: 74466

African (AFR) AF: 0.0237 AC: 986 AN: 41584

American (AMR) AF: 0.121 AC: 1846 AN: 15306

Ashkenazi Jewish (ASJ) AF: 0.101 AC: 349 AN: 3472

East Asian (EAS) AF: 0.137 AC: 706 AN: 5158

South Asian (SAS) AF: 0.0946 AC: 456 AN: 4820

European-Finnish (FIN) AF: 0.0485 AC: 515 AN: 10616

Middle Eastern (MID) AF: 0.116 AC: 34 AN: 294

European-Non Finnish (NFE) AF: 0.0804 AC: 5470 AN: 68024

Other (OTH) AF: 0.0855 AC: 181 AN: 2116

Alfa AF: 0.0849 Hom.: 964

Bravo AF: 0.0754

Asia WGS AF: 0.0880 AC: 308 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.84
CADD	Benign	0.0080
DANN	Benign	0.81
PhyloP100		-1.3
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs2241821; hg19: chr3-63976145; COSMIC: COSV107348740; COSMIC: COSV107348740;